Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy

Archives of Gynecology and Obstetrics

Volumn 281, Issue 5, 2010, Pages 801-810

  Wei, Jing ^a,b   Wang, Huimin ^a   Yang, Xiaofu ^a   Dong, Minyue ^a   Wang, Zhengping ^a  

^a Zhejiang University School of Medicine   (China)

^b TONGDE HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Gene profile; Intrahepatic cholestasis of pregnancy; Microarray; Placenta

Indexed keywords

ADENOSINE DEAMINASE; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; CXCL1 CHEMOKINE; GALANIN; INTERLEUKIN 1 RECEPTOR TYPE II; PROLACTIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; THROMBOCYTE FACTOR 2; TRANSCRIPTION FACTOR SP2; TRIACYLGLYCEROL LIPASE; VANILLOID RECEPTOR 5;

ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMMUNE RESPONSE; INTRAHEPATIC CHOLESTASIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLACENTA; PREGNANCY DISORDER; PREGNANT WOMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION;

ADULT; CASE-CONTROL STUDIES; CHOLESTASIS, INTRAHEPATIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 77950627780     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1156-3     Document Type: Article

References (45)

1. Lammert F, Marschall HU, Glantz A, Matern S (2000) Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 33(6):1012-1021
2. Beuers U, Pusl T (2006) Intrahepatic cholestasis of pregnancy-a heterogeneous group of pregnancy-related disorders? Hepatology 43(4):647-649.
3. Riely CA, Bacq Y (2004) Intrahepatic cholestasis of pregnancy. Clin liver dis 8(1):167-176
4. Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95(11):1137-1143
5. Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F (1997) Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 26(2):358-364
6. Rioseco AJ, Ivankovic MB, Manzur A et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170(3):890-895
7. Laatikainen T, Ikonen E (1975) Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn 64(3):155-164
8. Shaw D, Frohlich J, Wittmann BA, Willms M (1982) A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 142(6 Pt 1):621-625
9. Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM (1996) Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 175(4 Pt 1):957-960
10. Williamson C, Hems LM, Goulis DG et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111(7):676-681
11. Zhao YJ, Yue YF, Liu XQ, Li SH, Liu ZY, Wang Y (2004) Study on relationship between serum cholylglycine and placental apoptosis in patients with intrahepatic cholestasis of pregnancy (in Chinese). Zhonghua Fu Chan Ke Za Zhi 39(7):446-448
12. Wang DM, La XL, Ding L (2003) Study on apoptosis and expression of Fas, FasL in placenta of intrahepatic cholestasis of pregnancy (in Chinese). Chin J Perinat Med 6(4):199-201
13. Zhang SJ (2007) Immunohistochemical study on the expression of TNF-α in placenta in intrahepatic cholestasis of pregnancy (in Chinese). Acta Acad Med Xuzhou 27(7):451-452
14. Dong MY, He J, Wang ZP (2003) Placental expression of epidermal growth factor receptor in intrahepatic cholestasis of pregnancy. Chin J Obstet Gynecol 38(2):106-107
15. Watson A, Mazumder A, Stewart M, Balasubramanian S (1998) Technology for microarray analysis of gene expression. Curr Opin Biotechnol 9:609-614
16. Smith L, Greenfield A (2003) DNA microarrays and development. Hum Mol Genet 12(1):R1-R8
17. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(20):467-470
18. Dong M, Shi Y (1996) Evaluation of cholic glycine in serum and hemorrheological parameters in women with intrahepatic cholestasis of pregnancy (in Chinese). Curr Adv Obstet Gynecol 5:251-253
19. Dong M, Wang Z, He J, Shi Y, Yang P, Pan Y (1999) Increased anticardiolipin antibody in intrahepatic cholestasis of pregnancy (in Chinese). Chin J Obstet Gynecol 34:491
20. Dong M, Xie X, Wang Z, He J, Zhou J (2002) Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy (in Chinese). Gynecol Obstet Invest 54:191-195
21. Cristofalo VJ (2000) A DNA chip of aging block. Nat Med 6(5):507
22. Wang ZP, Dong MY, Chu HN, He J (2004) Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 83(11):1067-1070
23. Peng B, Liu SY (2002) Study of relationship between T helper cell type1 and type2 cytokines and intrahepatic cholestasis of pregnancy (in Chinese). Zhonghua Fu Chan Ke Za Zhi 37(9):516-518
24. Ling B, Yao FQ, Zhou Y, Chen ZZ, Shen GD, Zhu YY (2007) Cell-mediated immunity imbalance in patients with intrahepatic cholestasis of pregnancy. Cell Mol Immunol 4(1):71-75
25. Koehler LH, Benz EJ (1962) Serum adenosine deaminase: methodology and clinical applications. Clin Chem 8:133-140
26. Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ (1992) Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 38(7):1322-1326
27. Trajkovic V, Sweet MJ, Xu D (2004) T1/ST2-an IL-1 receptorlike modulator of immune responses. Cytokine Growth Factor Rev 15(2-3):87-95
28. Xu D, Chan WL, Leung BP et al (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187(5):787-794 (Pubitemid 28115194)
29. Löhning M, Stroehmann A, Coyle AJ et al (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95(12):6930-6935
30. Coyle AJ, Lloyd C, Tian J et al (1999) Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 190(7):895-902
31. Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM (2006) Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 107(1):106-114
32. Spreyer P, Schaal H, Kuhn G et al (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial Wbroblasts of peripheral nerve. EMBO J 9(8):2479-2484
33. Xia SY, Chen ZQ, Li L (2003) Change of vascular endothelial growth factor (VEGF) and its signiWcance in placenta for patients with intrahepatic cholestasis in pregnancy (in Chinese). J Chin Phys 5(8):1068-1070
34. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75(1):59-72
35. DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin- like growth factor II gene disrupted by targeting. Nature 345(6270):78-80
36. Lin CG, Leu SJ, Chen N et al (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278(26):24200-24208
37. Ellis PD, Chen Q, Barker PJ, Metcalfe JC, Kemp PR (2000) Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 20(8):1912-1919
38. Gellhaus A, Schmidt M, Dunk C, Lye SJ, Kimmig R, Winterhager E (2006) Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod 12(6):389-399
39. Chen M, Sun LZ, Ding HJ, Wu WP (2007) The relationship between intrahepatic cholestasis and placenta cells apoptosis in pregnancy (in Chinese). Mod Med J 35(6):428-431
40. Perez MJ, Macias RI, Marin JJ (2006) Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid. Placenta 27(1):34-41
41. Huang JR, Liu J, Chang SF (2006) Mechanism of farnesoid X receptor and bile salt excretory pump on bile acid transport in placenta of intrahepatic cholestasis of pregnany (in Chinese). Chongqing Med J 174:9-1950
42. Floreani A, Carderi I, Paternoster D et al (2008) Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 40(5):366-370
43. Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ (2008) Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 28:10:e9
44. Serrano MA, Macias RIR, Briz O et al (2007) Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 28:107-117
45. Patel P, Weerasekera N, Hitchins M, Boyd CAR, Johnston DG, Williamson C (2003) Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 24:39-44